 | • レポートコード：20QY06-05450 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、口蹄疫（FMD）ワクチンのグローバル市場について種類別（緊急ワクチン、従来型ワクチン）、用途別（牛、豚、羊・山羊、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・口蹄疫（FMD）ワクチン市場の概要 ・世界の主要地域別口蹄疫（FMD）ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の口蹄疫（FMD）ワクチン市場規模2015-2026：種類別（緊急ワクチン、従来型ワクチン） ・世界の口蹄疫（FMD）ワクチン市場規模2015-2026：用途別（牛、豚、羊・山羊、その他） ・口蹄疫（FMD）ワクチンの北米市場規模2015-2020 ・口蹄疫（FMD）ワクチンのヨーロッパ市場規模2015-2020 ・口蹄疫（FMD）ワクチンの中国市場規模2015-2020 ・口蹄疫（FMD）ワクチンの日本市場規模2015-2020 ・口蹄疫（FMD）ワクチンの東南アジア市場規模2015-2020 ・口蹄疫（FMD）ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jinyu Group、Cavet Bio、Indian Immunologicals、Tecon Group、CAHIC、Shen Lian、Biogenesis Bagó、BIGVET Biotech、Boehringer Ingelheim、MSD Animal Health、CEVA、FGBI、Bayer HealthCare、Brilliant Bio Pharma、VECOL、Sanofi (Merial)、VETAL、BVI、LIMOR、ME VAC、Agrovet） ・口蹄疫（FMD）ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・口蹄疫（FMD）ワクチンの市場動向・機会・課題 ・調査の結論 |
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
The classification of Foot and Mouth Disease Vaccines includes Emergency Vaccines and Conventional Vaccines, and the proportion of Conventional Vaccines in 2016 is about 70%, and the proportion is decreasing trend from 2012 to 2016.
Foot and Mouth Disease Vaccines are widely used for Cattle, Pig, Sheep & Goat and Others. The most proportion of Foot and Mouth Disease Vaccines is used for Cattle, and the consumption proportion is about 70.2% in 2016. The high adoption in the market segment can be attributed to the presence of an increasing number of cattle to meet the increased demand for its livestock products. Currently, India accounts for the largest cattle inventory worldwide, followed by Brazil and China. With the growing demand for cattle products worldwide, there is an increased need to reduce the impact of FMD outbreaks, leading to high demand for the FMD vaccine.
China region is the largest supplier of Foot and Mouth Disease Vaccines, with a production market share nearly 71.7% in 2016. South America is the second largest supplier of Foot and Mouth Disease Vaccines, enjoying production market share nearly 16.5% in 2016.
China is the largest consumption place, with a consumption market share nearly 69.2% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 20.4%.
Market Analysis and Insights: Global Foot and Mouth Disease (FMD) Vaccines Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Foot and Mouth Disease (FMD) Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Foot and Mouth Disease (FMD) Vaccines industry.
Based on our recent survey, we have several different scenarios about the Foot and Mouth Disease (FMD) Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 875.6 million in 2019. The market size of Foot and Mouth Disease (FMD) Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Foot and Mouth Disease (FMD) Vaccines Scope and Market Size
The global Foot and Mouth Disease (FMD) Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Foot and Mouth Disease (FMD) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Foot and Mouth Disease (FMD) Vaccines market is segmented into
Emergency Vaccines
Conventional Vaccines
Segment by Application, the Foot and Mouth Disease (FMD) Vaccines market is segmented into
Cattle
Pig
Sheep & Goat
Others
The Foot and Mouth Disease (FMD) Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Foot and Mouth Disease (FMD) Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Foot and Mouth Disease (FMD) Vaccines Market Share Analysis
Foot and Mouth Disease (FMD) Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Foot and Mouth Disease (FMD) Vaccines business, the date to enter into the Foot and Mouth Disease (FMD) Vaccines market, Foot and Mouth Disease (FMD) Vaccines product introduction, recent developments, etc.
The major vendors covered:
Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet
1 Foot and Mouth Disease (FMD) Vaccines Market Overview
1.1 Foot and Mouth Disease (FMD) Vaccines Product Scope
1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2020-2026)
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccines Segment by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Others
1.4 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Foot and Mouth Disease (FMD) Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Foot and Mouth Disease (FMD) Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Foot and Mouth Disease (FMD) Vaccines Industry
1.5.1.1 Foot and Mouth Disease (FMD) Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Foot and Mouth Disease (FMD) Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Foot and Mouth Disease (FMD) Vaccines Players to Combat Covid-19 Impact
2 Foot and Mouth Disease (FMD) Vaccines Estimate and Forecast by Region
2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
2.4.3 China Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
2.4.6 India Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2015-2026)
3 Global Foot and Mouth Disease (FMD) Vaccines Competition Landscape by Players
3.1 Global Top Foot and Mouth Disease (FMD) Vaccines Players by Sales (2015-2020)
3.2 Global Top Foot and Mouth Disease (FMD) Vaccines Players by Revenue (2015-2020)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2019)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Foot and Mouth Disease (FMD) Vaccines Players (Opinion Leaders)
4 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2014-2020)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2021-2026)
5 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2015-2020)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2021-2026)
3 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
3.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
4 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
4.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
5 China Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
5.2 China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
5.3 China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
5.4 China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
6 Japan Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
6.2 Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
7.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
8 India Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
8.2 India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
8.3 India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
8.4 India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Foot and Mouth Disease (FMD) Vaccines Business
12.1 Jinyu Group
12.1.1 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.1.2 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Products Offered
12.1.5 Jinyu Group Recent Development
12.2 Cavet Bio
12.2.1 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.2.2 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Products Offered
12.2.5 Cavet Bio Recent Development
12.3 Indian Immunologicals
12.3.1 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.3.2 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Products Offered
12.3.5 Indian Immunologicals Recent Development
12.4 Tecon Group
12.4.1 Tecon Group Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.4.2 Tecon Group Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Products Offered
12.4.5 Tecon Group Recent Development
12.5 CAHIC
12.5.1 CAHIC Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.5.2 CAHIC Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Products Offered
12.5.5 CAHIC Recent Development
12.6 Shen Lian
12.6.1 Shen Lian Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.6.2 Shen Lian Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Products Offered
12.6.5 Shen Lian Recent Development
12.7 Biogenesis Bagó
12.7.1 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.7.2 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Products Offered
12.7.5 Biogenesis Bagó Recent Development
12.8 BIGVET Biotech
12.8.1 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.8.2 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Products Offered
12.8.5 BIGVET Biotech Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.9.2 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 MSD Animal Health
12.10.1 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.10.2 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Products Offered
12.10.5 MSD Animal Health Recent Development
12.11 CEVA
12.11.1 CEVA Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.11.2 CEVA Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Products Offered
12.11.5 CEVA Recent Development
12.12 FGBI
12.12.1 FGBI Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.12.2 FGBI Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Products Offered
12.12.5 FGBI Recent Development
12.13 Bayer HealthCare
12.13.1 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.13.2 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Products Offered
12.13.5 Bayer HealthCare Recent Development
12.14 Brilliant Bio Pharma
12.14.1 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.14.2 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Products Offered
12.14.5 Brilliant Bio Pharma Recent Development
12.15 VECOL
12.15.1 VECOL Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.15.2 VECOL Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Products Offered
12.15.5 VECOL Recent Development
12.16 Sanofi (Merial)
12.16.1 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.16.2 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Products Offered
12.16.5 Sanofi (Merial) Recent Development
12.17 VETAL
12.17.1 VETAL Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.17.2 VETAL Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Products Offered
12.17.5 VETAL Recent Development
12.18 BVI
12.18.1 BVI Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.18.2 BVI Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Products Offered
12.18.5 BVI Recent Development
12.19 LIMOR
12.19.1 LIMOR Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.19.2 LIMOR Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Products Offered
12.19.5 LIMOR Recent Development
12.20 ME VAC
12.20.1 ME VAC Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.20.2 ME VAC Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Products Offered
12.20.5 ME VAC Recent Development
12.21 Agrovet
12.21.1 Agrovet Foot and Mouth Disease (FMD) Vaccines Corporation Information
12.21.2 Agrovet Foot and Mouth Disease (FMD) Vaccines Business Overview and Total Revenue
12.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Products Offered
12.21.5 Agrovet Recent Development
13 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis
13.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
13.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Foot and Mouth Disease (FMD) Vaccines Distributors List
14.3 Foot and Mouth Disease (FMD) Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Growth Rate by Type (2020-2026)
Table 2. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Foot and Mouth Disease (FMD) Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Foot and Mouth Disease (FMD) Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Foot and Mouth Disease (FMD) Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Foot and Mouth Disease (FMD) Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Region (2015-2020)
Table 10. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Forecast by Region (2021-2026)
Table 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Foot and Mouth Disease (FMD) Vaccines (K L) of Key Companies (2015-2020)
Table 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Company (2015-2020)
Table 19. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2019)
Table 22. Global Foot and Mouth Disease (FMD) Vaccines Average Price (USD/L) of Key Company (2015-2020)
Table 23. Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Foot and Mouth Disease (FMD) Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Foot and Mouth Disease (FMD) Vaccines Players
Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2015-2020)
Table 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Foot and Mouth Disease (FMD) Vaccines Price (K L) by Type (2015-2020)
Table 31. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2021-2026)
Table 32. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Foot and Mouth Disease (FMD) Vaccines Price (K L) by Type (2021-2026)
Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2015-2020)
Table 37. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Foot and Mouth Disease (FMD) Vaccines Price (K L) by Application (2015-2020)
Table 39. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2021-2026)
Table 40. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2021-2026)
Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Foot and Mouth Disease (FMD) Vaccines Price (K L) by Application (2021-2026)
Table 44. United States Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 45. United States Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 47. United States Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 49. United States Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 51. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 53. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 55. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 57. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 59. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 61. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 63. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 65. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 67. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 69. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 71. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 73. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Company (2015-2020)
Table 75. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2015-2020)
Table 77. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2015-2020)
Table 79. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2015-2020)
Table 80. Jinyu Group Corporation Information
Table 81. Jinyu Group Description and Business Overview
Table 82. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 83. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
Table 84. Jinyu Group Recent Development
Table 85. Cavet Bio Corporation Information
Table 86. Cavet Bio Description and Business Overview
Table 87. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 88. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
Table 89. Cavet Bio Recent Development
Table 90. Indian Immunologicals Corporation Information
Table 91. Indian Immunologicals Description and Business Overview
Table 92. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 93. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
Table 94. Indian Immunologicals Recent Development
Table 95. Tecon Group Corporation Information
Table 96. Tecon Group Description and Business Overview
Table 97. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 98. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
Table 99. Tecon Group Recent Development
Table 100. CAHIC Corporation Information
Table 101. CAHIC Description and Business Overview
Table 102. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 103. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
Table 104. CAHIC Recent Development
Table 105. Shen Lian Corporation Information
Table 106. Shen Lian Description and Business Overview
Table 107. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 108. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
Table 109. Shen Lian Recent Development
Table 110. Biogenesis Bagó Corporation Information
Table 111. Biogenesis Bagó Description and Business Overview
Table 112. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 113. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
Table 114. Biogenesis Bagó Recent Development
Table 115. BIGVET Biotech Corporation Information
Table 116. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 117. BIGVET Biotech Description and Business Overview
Table 118. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
Table 119. BIGVET Biotech Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. MSD Animal Health Corporation Information
Table 126. MSD Animal Health Description and Business Overview
Table 127. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 128. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product
Table 129. MSD Animal Health Recent Development
Table 130. CEVA Corporation Information
Table 131. CEVA Description and Business Overview
Table 132. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 133. CEVA Foot and Mouth Disease (FMD) Vaccines Product
Table 134. CEVA Recent Development
Table 135. FGBI Corporation Information
Table 136. FGBI Description and Business Overview
Table 137. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 138. FGBI Foot and Mouth Disease (FMD) Vaccines Product
Table 139. FGBI Recent Development
Table 140. Bayer HealthCare Corporation Information
Table 141. Bayer HealthCare Description and Business Overview
Table 142. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 143. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product
Table 144. Bayer HealthCare Recent Development
Table 145. Brilliant Bio Pharma Corporation Information
Table 146. Brilliant Bio Pharma Description and Business Overview
Table 147. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 148. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product
Table 149. Brilliant Bio Pharma Recent Development
Table 150. VECOL Corporation Information
Table 151. VECOL Description and Business Overview
Table 152. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 153. VECOL Foot and Mouth Disease (FMD) Vaccines Product
Table 154. VECOL Recent Development
Table 155. Sanofi (Merial) Corporation Information
Table 156. Sanofi (Merial) Description and Business Overview
Table 157. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 158. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product
Table 159. Sanofi (Merial) Recent Development
Table 160. VETAL Corporation Information
Table 161. VETAL Description and Business Overview
Table 162. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 163. VETAL Foot and Mouth Disease (FMD) Vaccines Product
Table 164. VETAL Recent Development
Table 165. BVI Corporation Information
Table 166. BVI Description and Business Overview
Table 167. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 168. BVI Foot and Mouth Disease (FMD) Vaccines Product
Table 169. BVI Recent Development
Table 170. LIMOR Corporation Information
Table 171. LIMOR Description and Business Overview
Table 172. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 173. LIMOR Foot and Mouth Disease (FMD) Vaccines Product
Table 174. LIMOR Recent Development
Table 175. ME VAC Corporation Information
Table 176. ME VAC Description and Business Overview
Table 177. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 178. ME VAC Foot and Mouth Disease (FMD) Vaccines Product
Table 179. ME VAC Recent Development
Table . Agrovet Corporation Information
Table . Agrovet Description and Business Overview
Table . Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table . Agrovet Foot and Mouth Disease (FMD) Vaccines Product
Table . Agrovet Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Foot and Mouth Disease (FMD) Vaccines Distributors List
Table 188. Foot and Mouth Disease (FMD) Vaccines Customers List
Table 189. Market Key Trends
Table 190. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 191. Key Challenges
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Picture
Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application in 2020 & 2026
Figure 6. Cattle Examples
Figure 7. Pig Examples
Figure 8. Sheep & Goat Examples
Figure 9. Others Examples
Figure 10. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) Growth Rate (2015-2026)
Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Price Trends Growth Rate (2015-2026) (USD/L)
Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Foot and Mouth Disease (FMD) Vaccines Sales (K L) Growth Rate (2015-2026)
Figure 17. Europe Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Foot and Mouth Disease (FMD) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Foot and Mouth Disease (FMD) Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Foot and Mouth Disease (FMD) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Foot and Mouth Disease (FMD) Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Foot and Mouth Disease (FMD) Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in Foot and Mouth Disease (FMD) Vaccines 2015 & 2019
Figure 28. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2015-2020)
Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 34. United States Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2019
Figure 36. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 37. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2019
Figure 38. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2019
Figure 39. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 40. China Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2019
Figure 41. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2019
Figure 42. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 43. Japan Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2019
Figure 44. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2019
Figure 45. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 46. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2019
Figure 47. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2019
Figure 48. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2019
Figure 49. India Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application in 2019
Figure 50. Jinyu Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cavet Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Tecon Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. CAHIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Shen Lian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biogenesis Bagó Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. BIGVET Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. MSD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. CEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. FGBI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Brilliant Bio Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. VECOL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Sanofi (Merial) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. VETAL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. BVI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. LIMOR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. ME VAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Agrovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Key Raw Materials Price Trend
Figure 72. Manufacturing Cost Structure of Foot and Mouth Disease (FMD) Vaccines
Figure 73. Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
Figure 74. Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Porter's Five Forces Analysis
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
口蹄疫（FMD）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Foot and Mouth Disease (FMD) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1280.5 million by 2025, from USD 900.9 million in 2019. The …- 単純ヘルペスウイルス（HSV）ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…
- mRNAワクチンおよび治療薬の世界市場レポート2020 mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…